Skip to main content
CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
1.770
-0.080 (-4.32%)
Dec 5, 2025, 4:00 PM EST - Market closed

CytoMed Therapeutics Revenue

CytoMed Therapeutics had revenue of 450.69K SGD in the half year ending June 30, 2025, with 58.57% growth. This brings the company's revenue in the last twelve months to 729.88K, up 63.03% year-over-year. In the year 2024, CytoMed Therapeutics had annual revenue of 503.37K, down -0.86%.

Revenue (ttm)
729.88K SGD
Revenue Growth
+63.03%
P/S Ratio
35.64
Revenue / Employee
16,974 SGD
Employees
43
Market Cap
20.43M USD

Revenue Chart

* This company reports financials in SGD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024503.37K-4.36K-0.86%
Dec 31, 2023507.74K143.82K39.52%
Dec 31, 2022363.91K250.07K219.67%
Dec 31, 2021113.84K54.37K91.43%
Dec 31, 202059.47K--
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 435.16B
Johnson & Johnson 92.15B
Merck & Co. 64.24B
AbbVie 59.64B
Eli Lilly and Company 59.42B
AstraZeneca 58.13B
Novartis AG 56.37B
Novo Nordisk 49.58B
Revenue Rankings

GDTC News

More News